The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
MicroRNA analysis of fine-needle aspirates from pancreatic cancer.
Philip Agop Philip
Consultant or Advisory Role - Amgen; Bayer; BioCancell; Bristol-Myers Squibb; Curis; Lilly; Nektar; OSI Pharmaceuticals; Roche; Sanofi
Honoraria - Amgen; Bayer; Genentech; Novartis; Roche
Research Funding - Amgen; Bristol-Myers Squibb; Chugai Pharma; Genentech; GenVec; Lilly; Nektar; Novartis; Pfizer; Sanofi
Husain Saleh
No relevant relationships to disclose
Shadan Ali
No relevant relationships to disclose
Wei Chen
No relevant relationships to disclose
Paulette Palazzolo
No relevant relationships to disclose
Seema Sethi
No relevant relationships to disclose
Fazlul H. Sarkar
Research Funding - NIH